Press release – 1st December 2015

4P Pharma, SATT AxLR and IBMM have concluded a co-development agreement   Montpellier, December 1st 2015   In the context of an innovative medical drug development project for the treatment of cancers, called “Imiqualines”, the oncology-pharmaco-chemical and pharmaco-toxicological team of IBMM, SATT AxLR and 4P Pharma have concluded a co-development maturation agreement with a licensing […]

4P Pharma at BioFIT 2015

We will be attending BioFIT 2015 in Strasbourg, France, on next December 1st and 2nd. Come and meet us there to talk about innovation and learn more about our innovative model to accelerate preclinical drug development!  

4P Pharma in the news

logo 4p pharma

4P Pharma was featured in an article in Eco121, the North region economic magazine.  Lille and the North region , is a very dynamic area for biotech, and we are pleased to benefit from the collaboration of Lille Pasteur Institute and Eurasanté. Find the article written by O. Ducuing, here: http://www.eco121.fr/categorie/theme/entreprendre/